ABC-301 offers a Bio Better treatment approach for Inflammatory bowel diseases, addressing a significant global unmet need.
Patients worldwide
Market Opportunity
Enhanced sIgA-based anti-TNFα therapy addressing limitations of current biologics for IBD treatment
Demonstrated 2.5x greater mucosal distribution and improved therapeutic index vs. Adalimumab in preclinical models
Direct mucosal targeting with minimal systemic exposure, improving safety profile (ie. generation of ADA) and patient compliance
Abcely is shaping a pipeline designed to unlock new therapeutic and market opportunities.
The announcement of a cancer diagnosis is a tsunami that stops a life in its tracks, leaving indelible scars and even shattering it completely. Treatment offers repair and reconstruction, healing the body and restoring its integrity. Treatment through remission and healing gives a second chance at life, which takes on an enhanced, unprecedented and new value that every patient feels after being so afraid of losing it.
The ABCELY logo was inspired by the Japanese tradition of ceramic repair, which, instead of hiding fractures and scars, sublimates them by highlighting them in gold, creating a work of art of immense value while restoring its original functionality. Life is never the same after such an experience, both in body and soul. With humility, our logo seeks to symbolize a life rebuilt and sublimated after such a devastating illness.
